Troubled Federal Circuit Hobbles US Patent System31/07/2017 by Steven Seidenberg for Intellectual Property Watch Leave a CommentIt’s been another dismal term for the Federal Circuit Court of Appeals. Six of its patent law decisions were reviewed in the US Supreme Court’s 2016-17 term, and the Federal Circuit’s decisions were overturned in all six cases. That, unfortunately, is not surprising. Over the past 15 years, the tribunal once known as the nation’s “patent court” has seen many of its most important patent law decisions reversed by the Supreme Court– sometimes in withering opinions. This has seriously undermined the Federal Circuit’s power, reputation, jurisprudence, and (apparently) self-confidence – causing a major problem for the United States’ patent system.
Report From WHO Fair Pricing Meeting Shows Balanced Discussion28/07/2017 by William New, Intellectual Property Watch Leave a CommentA wide range of governments and stakeholders attended a closed meeting in the Netherlands in May to address the ongoing problem of pricing medicines to pay for research and the resulting lack of affordability of those medicines. The report from the World Health Organization-led meeting shows a range of points were made by participants and signals a move to change the global policy.
Information, Access, And Development: Setting A Course For The Sustainable Development Goals28/07/2017 by Intellectual Property Watch 1 CommentInformation is the raw material for decision-making. When individuals and groups make the right choices, based on good information, their chances of taking a full role in economic, social, cultural and civic life improve. They can better create and innovate, participate in politics, find and do their jobs well, and live healthily.Informed citizens and communities are also essential to the UN’s 2030 Agenda. We cannot have sustainable development when individuals are not able to deal with new choices and challenges autonomously, drawing on access to information. And we cannot have inclusive development, with no-one left behind, unless this access is real and meaningful for everyone.Libraries have long sought to do this, making sure that the world’s heritage is preserved and made accessible, allowing the sharing of knowledge between institutions and across borders, and giving children, families, students and others the chance to enjoy works which they could never afford to pay for individually.
Companies Prefer Trade Secrets To Patents To Protect Innovation, EUIPO Finds27/07/2017 by Dugie Standeford for Intellectual Property Watch 1 Comment“Despite their economic importance, and in particular their role in protecting returns from innovation, trade secrets are poorly studied and their relationship with patents is often misinterpreted,” the EU Intellectual Property Office (EUIPO) said in a study published this month. It used a survey of around 200,000 companies in Europe’s manufacturing and service industries to determine what factors influenced their choice between patents and trade secrets, as well as their overall use of both mechanisms. The results could help policy-makers, the Office said. It also holds out opportunities for innovative lawyers and intellectual property firms, said one IP management consultant.
Why Fair Dealing Is Not Destroying Canada Publishing25/07/2017 by Intellectual Property Watch 1 CommentFor the past few years, publishers around the world have engaged in a sustained campaign to hold up Canada as proof that making fair dealing more flexible for education will hurt publishers. Those efforts rarely tell the whole story: that paid access remains the primary source of materials in Canada, that educational copyright policies in Canada are primarily a function of court decisions not copyright reform (the emphasis on fair dealing came before the 2012 reforms), that global publishers were reporting marketplace challenges that have nothing to do with copyright, that Canadian publishers that supposedly stopped publishing were still in business, that court affidavits from Canadian publishers focus on many concerns other than copyright, and that a study from one Canadian publisher association highlighted issues such as open access and used book sales. University of Ottawa law professor Michael Geist expands on the reality of Canadian publishing and copyright law.
US, European Views On IP Management And Digital Business25/07/2017 by Guest contributor for Intellectual Property Watch Leave a CommentData-driven technologies are enabling the expansion of trade and data flows around the world. We have disruptive smart products, smart industrial processes, smart clouds and smart services. Traditional industries such as pharmaceuticals, chemical and mechanical engineering digitally transform production processes to generate custom-tailored services and improve competitiveness using artificial intelligence while new companies emerge with disruptive offers. Such artificial intelligence-based business models, however, are bringing about a rethinking in European regulations in relation to copyrights, such as that deployed by DeepMind and Pinterest, for instance, because machine learning may reproduce countless amounts of proprietary content to generate raw solutions. A recent event in Paris delved into these and other issues, including data ownership and access rights, as well as inventions by computers.
The Case For Nations To Act On Medicines Access23/07/2017 by William New, Intellectual Property Watch 2 CommentsNEW YORK — A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead?
WHO Prequalifies First Generic Hepatitis C Drug And First HIV Self-Test21/07/2017 by William New, Intellectual Property Watch Leave a CommentIn the days before this month’s AIDS conference being held in Paris, the World Health Organization has announced the prequalification of the first generic version of sofosbuvir, a “critical” medicine for treating hepatitis C. Treatment for hepatitis C under patent has been notoriously priced at extreme high levels, putting it out of reach of patients in economies of all sizes.
Six Inconvenient Truths About NAFTA Renegotiations21/07/2017 by Intellectual Property Watch 2 CommentsThe renegotiation of the North American Free Trade Agreement’s (NAFTA’s) standards on patents is not good news for Canada. Any give by Canada will be costly not only to our health care system, but also to Canadian innovators, write Jean-Frédéric Morin and Richard Gold.
WIPO Moves Slowly On Reduction In Compensation For Geneva-Based Staff20/07/2017 by Catherine Saez, Intellectual Property Watch Leave a CommentEarlier this year, the United Nations International Civil Service Commission called for a decrease in the compensation for the high cost of living for staff of Geneva-based United Nations agencies. At the World Intellectual Property Organization Program and Budget Committee last week, some countries asked why the decision was not reflected in the draft budget for 2018/2019. WIPO replied that discussions on the decision are ongoing among various agencies.
